RANDOMISED, DOUBLE-BLIND, ACTIVE-CONTROLLED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ZASTAPRAZAN COMPARED WITH ESOMEPRAZOLE IN EROSIVE OESOPHAGITIS [ZASTAPRAZAN EROSIVE REFLUX OESOPHAGITIS-1 STUDY (ZERO-1)]

Jung-Hwan Oh  1     Hyun-Soo Kim  2     Dae Young Cheung  3     Hang Lak Lee  4     Dong-Ho Lee  5     Gwang Ha Kim  6     Suck-Chei Choi  7     Yu Kyung Cho  8     Woo-Chul Chung  9     Ji Won Kim  10     Eunju Yu  11     Hyesoo Kwon  11     John Kim  11     Hwoon-Yong Jung  12    
1 Eunpyeong St. Mary's Hospital, Seoul, Korea, Republic of
2 Yonsei University, Wonju College of Medicine, Wonju, Korea, Republic of
3 College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of
4 Hanyang University Hospital, Seoul, Korea, Republic of
5 Seoul Natl University Bundang Hospital, Division of Gastroenterology, Seongnam, Korea, Republic of
6 Pusan National University School of Medicine, Busan, Korea, Republic of
7 Wonkwang University Hospital, Iksan, Korea, Republic of
8 The Catholic University of Korea, Seoul, Korea, Republic of
9 The Catholic University of Korea, St. Vincents Hospital, Suwon, Korea, Republic of
10 SMG-SNU Boramae Medical Center, Seoul, Korea, Republic of
11 Onconic Therapeutics, Seoul, Korea, Republic of
12 Asan Medical Center, Seoul, Korea, Republic of

Topic
Digestive Oncology, Oesophagus, Surgery

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing